Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Haleon PLC Sponsored ADR ( (HLN) ) just unveiled an announcement.
On June 27, 2025, Haleon PLC announced the completion of its acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co. Ltd, making it a wholly owned subsidiary. This strategic move, initially announced on April 15, 2025, for RMB 1,623 million, strengthens Haleon’s position in the Chinese market, which is crucial for its growth due to favorable structural drivers. The acquisition enhances Haleon’s operational flexibility and aligns with its capital allocation priorities, promising attractive returns for shareholders and maintaining a strong investment-grade balance sheet.
The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.
Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health through its extensive portfolio of products. The company operates across six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its long-standing brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are built on trusted science and innovation.
Average Trading Volume: 16,337,882
Technical Sentiment Signal: Buy
Current Market Cap: $47.32B
For an in-depth examination of HLN stock, go to TipRanks’ Overview page.